Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
Clinical trial NCT06894225 · SUSPENDED
Trial details
- NCT number
- NCT06894225
- Sponsor
- National Neuroscience Institute
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-22
- Primary completion
- 2026-05-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.